Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y8IS
|
|||
| Former ID |
DIB010820
|
|||
| Drug Name |
VP-025
|
|||
| Synonyms |
Inflammation therapeutics, Vasogen; VP-015
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Discontinued in Phase 1 | [1] | |
| Company |
Vasogen
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytokine receptor unspecific (CRF) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017461) | |||
| REF 2 | List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Dis 2007;4:443-486. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.